Kanade Shinkai, MD

Dermatologist

Dr. Kanade Shinkai is an attending physician in the Dermatology Clinic. She has expertise in dermatology of hospitalized, systemically ill patients. She sees patients with all types of skin disease but specializes in complex medical dermatology with a focus on autoimmune and autoinflammatory disorders of skin. Shinkai performs research on immunologic and inflammatory cutaneous diseases.

Clinics

Dermatology Clinic
1701 Divisadero St., Third and Fourth Floors
San Francisco, CA 94115
Phone: (415) 353–7800
Fax: (415) 353–7870

Hours: Monday to Friday, 8 a.m. – 5 p.m.

PCOS Clinic
499 Illinois St.
San Francisco, CA 94158
Phone: (415) 885-3674
Fax: (415) 353-7744

Hours: Two Thursdays a month
8 a.m. – 5 p.m.

Board Certification

Dermatology, American Board of Dermatology

Academic Title

Associate Professor

More about Kanade Shinkai

Education

UCSF School of Medicine 2004

Residencies

UCSF Medical Center, Dermatology 2008

Selected Research and Publications

  1. Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, Marzano AV, Wallach D, Kim K, Schadt C, Ormerod A, Fung MA, Steel A, Patel F, Qin R, Craig F, Williams HC, Powell F, Merleev A, Cheng MY. Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts. JAMA Dermatol. 2018 Apr 01; 154(4):461-466.
  2. Noe MH, Mostaghemi A, Rosenbach M, Shinkai K, Micheletti RG. Selective use of cyclosporine for Stevens-Johnson syndrome / toxic epidermal necrolysis may exclude patients with poor prognostic factors. J Invest Dermatol. 2018 Mar 17.
  3. Afifi L, North JP, Shinkai K. An enlarging, ulcerated scalp nodule. JAAD Case Rep. 2018 Apr; 4(3):211-213.
  4. Kushner T, Shinkai K, Fox L, Ying D, Gross A, Balitzer D, Gill R, Brandman D. New presentation of autoimmune hepatitis with erythema multiforme. Hepatology. 2018 Apr; 67(4):1628-1630.
  5. Walsh RK, Endicott AA, Shinkai K. Diagnosis and Treatment of Rosacea Fulminans: A Comprehensive Review. Am J Clin Dermatol. 2018 Feb; 19(1):79-86.
  6. Rojek NW, Shinkai K, Fett N. Dermatology faculty and residents' perspectives on the dermatology residency application process: A nationwide survey. J Am Acad Dermatol. 2018 Jan 04.
  7. Afifi L, Sanchez IM, Wallace MM, Braswell SF, Ortega-Loayza AG, Shinkai K. Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review. J Am Acad Dermatol. 2017 Dec 27.
  8. Saeed L, Schmidt TH, Gensler LS, Gross AJ, Fox LP, Scharschmidt TC, Gaensler K, Naik H, Rosenblum MA, Shinkai K. Successful treatment of mucous membrane pemphigoid with bortezomib. JAAD Case Rep. 2018 Jan; 4(1):81-83.
  9. Narala S, Loh T, Shinkai K, Paravar T. Characteristics of research tracks in dermatology residency programs: a national survey. Dermatol Online J. 2017 Dec 15; 23(12).
  10. Davari P, Millsop JW, Johnson MAN, Takahashi SR, Peng DH, Badger J, Bahr BA, Shinkai K, Li CS, Fazel N. Dermatology Medical Education: A Multicenter Survey Study of the Undergraduate Perspective of the Dermatology Clinical Clerkship. Dermatol Online J. 2017 Dec 15; 23(12).
  11. Linos E, Wintroub B, Shinkai K. Diversity in the dermatology workforce: 2017 status update. Cutis. 2017 Dec; 100(6):352-353.
  12. Shinkai K, Chen CA, Schwartz BS, Loeser H, Ashe C, Irby DM. Rethinking the Educator Portfolio: An Innovative Criteria-Based Model. Acad Med. 2017 Nov 07.
  13. Gantz M, Butler D, Goldberg M, Ryu J, McCalmont T, Shinkai K. Atypical features and systemic associations in extensive cases of Grover disease: A systematic review. J Am Acad Dermatol. 2017 Nov; 77(5):952-957.e1.
  14. Chen A, Shinkai K. Important Considerations for Diversity in the Selection of Dermatology Applicants. JAMA Dermatol. 2017 Sep 01; 153(9):949.
  15. Abrouk M, Farahnik B, Zhu TH, Nakamura M, Singh R, Lee K, Lucking SM, Blossom J, Liao W, Koo J, Bhutani T, Shinkai K, Nguyen T. Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses. J Am Acad Dermatol. 2017 07; 77(1):177-180.
  16. Chen CA, Shinkai K. Increasing Diversity in Dermatology Residencies-Reply. JAMA Dermatol. 2017 Jul 01; 153(7):728-729.
  17. Schmidt TH, Okhovat JP, Khanijow K, Huddleston H, Cedars M, Pasch L, Wang ET, Lee J, Shinkai K. Rotterdam criteria-based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study. J Am Acad Dermatol. 2017 07; 77(1):174-176.
  18. Granstein RD, Cornelius L, Shinkai K. Diversity in Dermatology-A Call for Action. JAMA Dermatol. 2017 Jun 01; 153(6):499-500.
  19. Maverakis E, Wang EA, Shinkai K, Mahasirimongkol S, Margolis DJ, Avigan M, Chung WH, Goldman J, La Grenade L, Pirmohamed M, Shear NH, Tassaeeyakul W, Hoetzenecker W, Klaewsongkram J, Rerkpattanapipat T, Manuyakorn W, Yasuda SU, Sharon VR, Sukhov A, Micheletti R, Struewing J, French LE, Cheng MY. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group. JAMA Dermatol. 2017 Jun 01; 153(6):587-592.
  20. Reid SP, Kao CN, Pasch L, Shinkai K, Cedars MI, Huddleston HG. Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study. Fertil Res Pract. 2017; 3:8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.